Expedited Versus Restrictive: Limitations on Activity Following Surgical Treatment of Prolapse
EVeRLAST
1 other identifier
interventional
123
1 country
1
Brief Summary
The objective of the EVeRLAST study is to determine whether expedited resumption of postoperative activity levels is non-inferior to standard activity restrictions with respect to short-term anatomic prolapse outcomes. We hypothesize that immediate resumption of physical activities as tolerated will result in noninferior surgical outcomes following prolapse surgery when compared to standard postoperative activity restrictions. Participants will be enrolled and randomized at their preoperative clinic visit to one of two treatment arms: Arm 1: Standard instructions (no heavy lifting over 10lbs for 6 weeks; return to work at 4 weeks for sedentary work and 6 weeks for manual labor) Arm 2: Liberal instructions (no restrictions; resume activities and work as soon as able) We will also collect subjective and objective measures of pre- and postoperative physical activity, through the use of patient-reported physical activity assessments and wrist-worn accelerometers. Accelerometer data will be collected at the preoperative, 2-week-postoperative, and 6-week-postoperative time points. Accelerometer data will also be used to calculate time to resumption of normal activities, defined as time at which a patient resumes greater than 90% of her baseline preoperative level of physical activity. We will additionally be collecting data on relevant patient-reported outcomes of pelvic floor symptom severity, health-related quality of life measures, postoperative pain, time to return to work (where relevant), and patient global impression of improvement. Postoperative anatomic assessments will be performed at 6 weeks and 3 months postoperatively by blinded study personnel
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2020
CompletedFirst Posted
Study publicly available on registry
April 1, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2022
CompletedMarch 8, 2022
February 1, 2022
1.6 years
March 30, 2020
February 21, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Maximum support loss "SLMax"
Most distal point of pelvic organ support (in centimeters) based on Pelvic Organ Prolapse Quantification system
3 months
Prolapse symptoms
Pelvic Organ Prolapse Distress Inventory (POPDI) at 3 months
3 months
Secondary Outcomes (11)
Recovery time
6 weeks
Health related quality of life (HRQOL)
3 months
Physical function
3 months
Physical function
3 months
Time to return to work
3 months
- +6 more secondary outcomes
Study Arms (2)
Expedited instructions
EXPERIMENTALRestricted instructions
ACTIVE COMPARATORInterventions
Ad lib postoperative activity and return to work recommendations
Standard conservative postoperative activity and return to work recommendations
Eligibility Criteria
You may qualify if:
- Stage II-IV pelvic organ prolapse
- Bothersome bulge symptoms
- At least 725 MET-minutes/week on International Physical Activity Questionnaire Short Form
- English-speaking
- Undergoing treatment of prolapse
- Surgery occurring at least 7 days from date of randomization (to allow for collection of at least 7 days of preoperative accelerometer data)
- Able and willing to follow up at 3 months for in-office exam
You may not qualify if:
- Enrollment in another research study of pelvic organ prolapse
- Concomitant non-urogynecologic surgery
- Planned further surgery in the next 3 months or anticipated treatment which would result in prolonged inactivity (such as a cancer diagnosis) 3 months postoperatively
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (3)
Brubaker L, Barber MD, Nygaard I, Nager CW, Varner E, Schaffer J, Visco A, Meikle S, Spino C; Pelvic Floor Disorders Network. Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol. 2010 Nov;203(5):512.e1-6. doi: 10.1016/j.ajog.2010.06.071. Epub 2010 Aug 21.
PMID: 20728072BACKGROUNDTomioka K, Iwamoto J, Saeki K, Okamoto N. Reliability and validity of the International Physical Activity Questionnaire (IPAQ) in elderly adults: the Fujiwara-kyo Study. J Epidemiol. 2011;21(6):459-65. doi: 10.2188/jea.je20110003. Epub 2011 Sep 24.
PMID: 21946625BACKGROUNDO'Shea M, Siddiqui NY, Truong T, Erkanli A, Barber MD. Standard Restrictions vs Expedited Activity After Pelvic Organ Prolapse Surgery: A Randomized Clinical Trial. JAMA Surg. 2023 Aug 1;158(8):797-805. doi: 10.1001/jamasurg.2023.1649.
PMID: 37256578DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Barber, MD, MHS
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Surgical treatment teams and outcome assessors will be blinded to patient's treatment arm.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2020
First Posted
April 1, 2020
Study Start
July 1, 2020
Primary Completion
February 15, 2022
Study Completion
February 15, 2022
Last Updated
March 8, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share